Allosteric targeting resolves limitations of earlier LFA-1 directed modalities

Type
01A - Journal article
Editors
Editor (Corporation)
Supervisor
Parent work
Biochemical Pharmacology
Special issue
DOI of the original publication
Link
Series
Series number
Volume
211
Issue / Number
Pages / Duration
Patent number
Publisher / Publishing institution
Elsevier
Place of publication / Event location
Edition
Version
Programming language
Assignee
Practice partner / Client
Keywords
Project
Event
Exhibition start date
Exhibition end date
Conference start date
Conference end date
Date of the last check
ISBN
ISSN
0006-2952
1873-2968
Language
English
Created during FHNW affiliation
Yes
Strategic action fields FHNW
Publication status
Published
Review
Peer review of the complete publication
Open access category
Closed
License
Citation
Mancuso, R. V., Schneider, G., Hürzeler Müller, M., Gut, M., Zurflüh, J., Breitenstein, W., Bouitbir, J., Reisen, F., Atz, K., Ehrhardt, C., Duthaler, U., Gygax, D., Schmidt, A. G., Krähenbühl, S., & Weitz-Schmidt, G. (2023). Allosteric targeting resolves limitations of earlier LFA-1 directed modalities. Biochemical Pharmacology, 211. https://doi.org/10.1016/j.bcp.2023.115504